Every record from Medutest · page 14
Fast turnaround and the widest compound acceptance, at unit mass resolution rather than high resolution. Measured offset against the reference laboratory is +0.065 pp on 517 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020124 | Retatrutide | GGPeps | GGPE-2508-E8992 | 2025-Q3 | 98.77 | 2.59 | 99.1 | Supplier-supplied | 2 | FAIL |
| AX-2025-020770 | Semaglutide | SGN | SGN-2502-F9601 | 2025-Q3 | 99.79 | 5.04 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020668 | SS-31 (Elamipretide) | GL Biochem | GLBI-2507-R8450 | 2025-Q3 | 98.54 | 2.87 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020594 | Retatrutide | SSA | SSA-2508-N7223 | 2025-Q3 | 97.78 | 3.57 | 97.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018681 | Dihexa | QYB | QYB-2503-Y6694 | 2025-Q3 | 99.88 | 7.09 | 100.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021107 | Tirzepatide | WXT | WXT-2505-T4814 | 2025-Q3 | 97.53 | 3.59 | 99.1 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019189 | Tirzepatide | TFC | TFC-2507-T5380 | 2025-Q3 | 97.98 | 3.71 | 104.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021269 | Pemvidutide | BCH | BCH-2506-G6608 | 2025-Q3 | 97.63 | 6.04 | 107.2 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-018492 | MOTS-c | WWB | WWB-2507-K2916 | 2025-Q3 | 99.93 | 3.61 | 102.2 | Supplier-supplied | 0 | PASS |
| AX-2025-019367 | Tirzepatide | TFC | TFC-2503-P7552 | 2025-Q3 | 99.87 | 4.66 | 100.2 | Supplier-supplied | 2 | FAIL |
| AX-2025-021053 | Semaglutide | WXT | WXT-2508-G4316 | 2025-Q3 | 99.18 | 2.18 | 95.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020958 | CJC-1295 (no DAC) | CPC | CPC-2503-R2710 | 2025-Q3 | 97.90 | 5.73 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-020886 | BPC-157 | CPC | CPC-2503-T1811 | 2025-Q3 | 99.37 | 3.65 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-021048 | Semaglutide | WXT | WXT-2508-G4316 | 2025-Q3 | 97.94 | 3.46 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2025-020046 | Semaglutide | ERP | ERP-2502-K7355 | 2025-Q3 | 98.40 | 2.61 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021262 | Pemvidutide | BCH | BCH-2506-G6608 | 2025-Q3 | 97.98 | 5.23 | 97.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021261 | Pemvidutide | BCH | BCH-2506-G6608 | 2025-Q3 | 98.70 | 5.41 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020824 | GHRP-6 | SGN | SGN-2504-X1136 | 2025-Q3 | 99.54 | 3.75 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019314 | Retatrutide | TFC | TFC-2508-H7325 | 2025-Q3 | 97.34 | 3.38 | 100.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018676 | Dihexa | QYB | QYB-2503-Y6694 | 2025-Q3 | 99.93 | 7.81 | 107.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020673 | SS-31 (Elamipretide) | GL Biochem | GLBI-2507-R8450 | 2025-Q3 | 98.09 | 2.91 | 89.6 | Supplier-supplied | 2 | FAIL |
| AX-2025-019832 | Semaglutide | SWB | SWB-2504-Y4284 | 2025-Q3 | 99.76 | 2.83 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020757 | BPC-157 | SGN | SGN-2507-F9952 | 2025-Q3 | 97.90 | 4.28 | 106.3 | Buyer-sourced | 2 | FAIL |
| AX-2025-020643 | MOTS-c | SSA | SSA-2503-S7755 | 2025-Q3 | 99.29 | 4.65 | 104.3 | Buyer-sourced | 0 | PASS |
| AX-2025-020358 | Liraglutide | MKM | MKM-2508-P3929 | 2025-Q3 | 98.55 | 6.63 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019667 | Semaglutide | Homopeptide | HOMO-2505-X2210 | 2025-Q3 | 99.34 | 2.74 | 93.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020645 | MOTS-c | SSA | SSA-2503-S7755 | 2025-Q3 | 99.61 | 5.30 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019234 | NAD+ | TFC | TFC-2505-C6056 | 2025-Q3 | 99.49 | 11.76 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020554 | L-Glutathione (reduced) | SSA | SSA-2506-X6030 | 2025-Q3 | 98.14 | 8.58 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019109 | BPC-157 | JEEP | JEEP-2507-V4206 | 2025-Q3 | 99.93 | 4.43 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021244 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | 2025-Q3 | 98.23 | 7.25 | 97.1 | Supplier-supplied | 0 | FAIL |
| AX-2025-021088 | PT-141 (Bremelanotide) | WXT | WXT-2507-R5522 | 2025-Q3 | 99.50 | 5.15 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020828 | GHRP-6 | SGN | SGN-2504-X1136 | 2025-Q3 | 98.79 | 3.97 | 93.2 | Buyer-sourced | 2 | FAIL |
| AX-2025-020669 | SS-31 (Elamipretide) | GL Biochem | GLBI-2507-R8450 | 2025-Q3 | 98.00 | 3.59 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019984 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 99.36 | 3.56 | 103.1 | Supplier-supplied | 2 | FAIL |
| AX-2025-019732 | Ipamorelin | HJ | HJ-2504-X2985 | 2025-Q3 | 99.86 | 6.78 | 96.3 | Supplier-supplied | 0 | PASS |
| AX-2025-020732 | Tirzepatide | SGN | SGN-2506-J8941 | 2025-Q3 | 97.85 | 2.21 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-018735 | Semaglutide | QSC | QSC-2412-F7396 | 2025-Q2 | 99.12 | 3.14 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020598 | Tirzepatide | SSA | SSA-2502-D7115 | 2025-Q3 | 97.70 | 6.70 | 93.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020430 | Tirzepatide | KP | KP-2504-V4847 | 2025-Q3 | 98.50 | 4.92 | — | Supplier-supplied | 2 | MARGINAL |